18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT

Leukemia & Lymphoma
N George MikhaeelM N Maisey

Abstract

Less than 50% of newly diagnosed patients with aggressive histology Non-Hodgkin's Lymphoma (NHL) are cured with standard treatment. The ability to accurately monitor response to treatment is crucial in order to select out patients who need more intensive or salvage treatment. This study assesses the accuracy of FDG-PET as compared to CT in remission assessment following treatment of aggressive NHL, and its value in estimating relapse-free survival. It also evaluates the prognostic value of early interim PET scan in prediction of treatment outcome. Forty-nine adult patients with biopsy-proven aggressive NHL between September 1993 and December 1997 were included. All patients had pre-treatment FDG-PET demonstrating increased uptake in sites of disease. Forty-five patients had a post-treatment PET to assess remission status and 4 had an interim but not a post-treatment PET. Thirty-three of these patients also had a pre- and a post-treatment CT scan. Twenty-three of the 49 patients had an interim PET during chemotherapy to assess early response. PET and CT scan results were correlated with relapse data to examine their accuracy in remission assessment and prediction of prognosis. The median follow-up duration is 30 months. Overall ...Continue Reading

References

Dec 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L F VerdonckH K Nieuwenhuis
Dec 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W D KaplanG P Canellos
Dec 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SurboneR C Young
Jun 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G P Canellos
Aug 1, 1982·Journal of Computer Assisted Tomography·E LewisJ L Thomas
May 1, 1995·European Journal of Nuclear Medicine·A Dimitrakopoulou-StraussG van Kaick
Jan 1, 1995·Seminars in Nuclear Medicine·D Front, O Israel
Aug 1, 1994·Annals of Nuclear Medicine·J OkadaN Arimizu
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W MillsA H Goldstone
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jan 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M de WitD K Hossfeld
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M JanicekM A Shipp
Feb 6, 1999·European Journal of Nuclear Medicine·M A LodgeM A Smith

❮ Previous
Next ❯

Citations

Aug 4, 2007·Medical Oncology·Ronan SwordsFrancis Giles
Aug 23, 2003·Annals of Nuclear Medicine·Hirofumi KogaHiroshi Honda
Apr 25, 2012·Der Radiologe·A Afshar-OromiehF L Giesel
Apr 5, 2003·European Journal of Nuclear Medicine and Molecular Imaging·P J Hoskin
Apr 24, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Karoline SpaepenLuc Mortelmans
Jun 17, 2006·European Journal of Nuclear Medicine and Molecular Imaging·N George Mikhaeel
Jun 2, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Andreas K BuckSven N Reske
Jan 26, 2008·European Journal of Nuclear Medicine and Molecular Imaging·G Moulin-RomseeL Mortelmans
Apr 4, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Lale Kostakoglu
Oct 27, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Juliano Julio CerciJoão Vicente Vitola
Jan 25, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Silvia FuertesFrancesca Pons
Jul 28, 2006·Annals of Hematology·Solène QuerellouOlivier Couturier
Dec 21, 2006·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Ching-yee Oliver WongConrad Nagle
Jan 16, 2008·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Phillip H KuoMichael Girardi
Nov 1, 2011·Annals of Nuclear Medicine·Shingo BabaHiroshi Honda
Aug 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Sarah S Donaldson
Aug 12, 2010·Nature Reviews. Clinical Oncology·Sandip Basu
Oct 10, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H S HanI S Lossos
Mar 25, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C JacksonA Wotherspoon
Aug 3, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J A DorthC R Kelsey
Apr 13, 2004·Current Opinion in Oncology·Yvette L KasamonLode J Swinnen
Dec 13, 2005·Nuclear Medicine Communications·Tamás GyörkeIngo Brink
Aug 5, 2010·Current Opinion in Oncology·Anne-Sophie MichalletChristelle Tychyj-Pinel
Apr 7, 2007·Nuclear Medicine Communications·Anna M Kirby, N George Mikhaeel
Sep 29, 2007·Nuclear Medicine Communications·Dimitrios KarantanisGregory A Wiseman
Aug 6, 2009·Nuclear Medicine Communications·Yiyan Liu
Sep 13, 2005·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·S F Hain
Dec 20, 2005·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Alain RahmouniEmmanuel Itti
Nov 23, 2006·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins
Oct 6, 2007·Blood·Thomas C KweeRutger A J Nievelstein
Jun 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hubert H ChuangMouhammed Amir Habra
Apr 24, 2007·Bulletin du cancer·Catherine PatteLaurence Brugières
Dec 7, 2010·Indian Journal of Cancer·A M Samuel
Jun 24, 2005·PLoS Medicine·Catherine Burton
Jan 18, 2005·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Toshiki KazamaHomer A Macapinlac
Mar 27, 2007·Future Oncology·Norbert Avril, David Propper
Mar 27, 2002·European Journal of Nuclear Medicine and Molecular Imaging·P J Hoskin
Feb 13, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Lale Kostakoglu, Bruce D Cheson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.